Drug
SR 46349B clinical trials
Also written Eplivanserin.
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Related medicines
As reviewed, each with the page that says it.
- One of Fibrinolytic Agents source
Studies
Open first, then newest update. How each study uses SR 46349B is read from its arms, and is right about nine times in ten.
Testing it · 7
- Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance DifficultiesCompletedPhase 3SanofiNCT00805350Written as Eplivanserin
- Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance InsomniaCompletedPhase 3SanofiNCT00253968Written as Eplivanserin
- Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With InsomniaCompletedPhase 1SanofiNCT00913614Written as Eplivanserin (SR46349)
- Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance DifficultiesCompletedPhase 3SanofiNCT00679900Written as eplivanserin (SR46349)
- Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 YearCompletedPhase 3SanofiNCT00253903Written as eplivanserin (SR46349)
- Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance InsomniaCompletedPhase 3SanofiNCT00308503Written as eplivanserin (SR46349)
- Efficacy and Safety of SR46349B in Patients With Sleep Disorders in FibromyalgiaCompletedPhase 2SanofiNCT00313885Written as eplivanserin (SR46349)
Codes
What other systems call SR 46349B · ClinicalTrials.gg INT003650
- MeSH (NLM) C076033SR 46349BOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C076033 | SR 46349B | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.